TSXV: ARTGCapital-efficient, $1.44 billion expanded Phase 2 ("EP2") development of processing capacity to 21 Mtpa expected to be funded from operating ...
This study reports a valuable method to predict the capacity of a candidate probiotic bacterium to metabolically outcompete a bacterial pathogen in the ecological niche of the murine respiratory tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback